Key result
Elevated plasma levels of ceramide 22:0 were associated with the presence of carotid atherosclerotic plaques compared to healthy controls, independent of cholesterol levels.
Why the study?
Plasma lipidomics allows study of a wide spectrum of lipid species, but the roles of plasma lipid components in relation to atherosclerotic plaques needed exploration.
Case-Control (n=20)
Randomly selected from a community cohort
No
Elevated plasma ceramide 22:0 is independently associated with carotid atherosclerotic plaques, suggesting it may be a novel biomarker and potential therapeutic target for atherosclerosis.
Answers are grounded in this paper and cite their sources.
Ceramide 22:0 may mark carotid atherosclerosis beyond cholesterol; hypothesis-generating and leaves open prospective validation for risk stratification.
Abstract Background: The rapidly growing discipline of lipidomics allows the study of a wide spectrum of lipid species in human plasma and provides new insights into the pathogenesis of atherosclerosis. Objective: To explore the roles of plasma lipid components in relation to atherosclerotic plaques.Methods: Ten non-symptomatic persons (age 62.42±3.45) with 2 or more carotid plaques (soft or mixed) and ten apparently healthy controls without any carotid plaque (age 62.82±4.38), were randomly selected as cases and controls from a community-based sample of 1312 persons. Ultra-performance liquid chromatography coupled with electrospray ionization quadrupole mass spectrometry (UPLC-ESI-QTOF MS)-based lipidomics was used to measure lipid components. The difference of lipid species between cases and controls was analyzed by t-test and general linear regression. Results: Among 53 lipid components, significantly elevated plasma levels of one novel individual ceramide species (ceramide 22: 0) were observed in cases compared to the controls (0.59±0.18 versus 0.41±0.10μg/mL, p values<0.05). After adjusting for confounding factors, such as total cholesterol and low-density lipoprotein cholesterol, the results remained significant (p<0.05). 22:0 ceramide was significantly negatively correlated with vegetable intake (r=-0.74, p=0.014).Conclusion: High level of plasma ceramide 22:0 may be a novel risk factor for carotid atherosclerosis in human which independent of cholesterol and low-density lipoprotein cholesterol, it deserves future studies with larger sample size to confirm.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2020) conducted a case-control in Carotid atherosclerotic plaque (n=20). Plasma ceramide 22:0 vs. Healthy controls without carotid plaque was evaluated on Plasma level of ceramide 22:0 (μg/mL) (p=<0.05). Elevated plasma levels of ceramide 22:0 were associated with the presence of carotid atherosclerotic plaques compared to healthy controls, independent of cholesterol levels.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: